Top Markets
#1 Trillions Trillions +5,128.37%
#2 DeFiChain DeFiChain +1,700.88%
#3 Bedrock Bedrock +163.86%
#4 Siren Siren +91.29%
#5 KONET KONET +60.65%
#6 inSure DeFi inSure DeFi +59.52%
#7 Banana For Scale Banana For Scale +44.28%
#8 Aria.AI Aria.AI +38.69%
#9 Syndicate Syndicate +37.36%
#10 Janction Janction +32.88%
Coin of the day
Trillions Trillions
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVB
Peringkat dalam Saham #99999
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the... Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Harga Saham
$0.09933121
Kapitalisasi Pasar
$29.15K
Perubahan (1 hari)
0.57%
Perubahan (1 tahun)
449.49%
Negara
IE
Perdagangan Ovoca Bio plc (OVB)

Kategori

Healthcare
Rasio P/B untuk Ovoca Bio plc (OVB)
Rasio P/B per March 2026 TTM: 0.32
Menurut laporan keuangan dan harga saham terbaru dari Ovoca Bio plc, rasio P/B saat ini (TTM) adalah 0.32. Pada akhir 2022, rasio P/B perusahaan adalah 0.64.
Riwayat rasio P/B untuk Ovoca Bio plc dari 2001 hingga 2026
Rasio P/B pada akhir setiap tahun
Tahun Rasio P/B Mengubah
2026 (TTM) 0.32 5.10%
2023 0.30 -53.15%
2022 0.64 -29.64%
2021 0.91 118.10%
2020 0.42 -3.84%
2019 0.43 -6.34%
2018 0.46 53.47%
2017 0.30 -32.59%
2016 0.45 47.37%
2015 0.30 -7.99%
2014 0.33 9.22%
2013 0.30 -0.88%
2012 0.31 -37.76%
2011 0.49 -30.05%
2010 0.70 56.65%
2009 0.45 86.66%
2008 0.24 -82.53%
2007 1.37 8.35%
2006 1.27 -10.71%
2005 1.42 46.67%
2004 0.97 -4.43%
2003 1.01 -25.12%
2002 1.35 -22.97%
2001 1.76 0.00%
Rasio P/B untuk perusahaan sejenis atau pesaing
Perusahaan Rasio P/B Perbedaan Rasio P/B Negara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 5.6573 1,694.26%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3842 1,924.80%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.4551 678.66%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.364 1,284.08%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 5.9034 1,772.31%
NL